Sunrise, Fla.-based OrthoSensor received FDA 510(k) clearance for its VERASENSE knee system, an instrument system for implant position during total knee replacements. The device is designed to replace the standard plastic tibial trial spacer and uses proprietary technology to give surgeons real-time feedback on limb alignment and implant position.
OrthoSensor also announced recently that Stryker's orthopedics division will co-market the VERASENSE.
More Articles on Devices:
Professor Moshe Shoham Receives Award for Inventing Renaissance Robotic System
Jury Sides with Depuy-Synthes in $16M Patent Infringement Ruling Against Globus
Medtronic Receives CE Mark, Initiates European Launch of Spinal Deformity Instrument
OrthoSensor also announced recently that Stryker's orthopedics division will co-market the VERASENSE.
More Articles on Devices:
Professor Moshe Shoham Receives Award for Inventing Renaissance Robotic System
Jury Sides with Depuy-Synthes in $16M Patent Infringement Ruling Against Globus
Medtronic Receives CE Mark, Initiates European Launch of Spinal Deformity Instrument